HCW Biologics Inc. (HCWB) has 60 open-market insider trades by 8 insiders since 2021. Over the last six months insiders net bought $530K. The most active filer is Rebecca Byam, CFO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Hing C. Wong | CEO10% Owner | — | 16 | $8.0M | 2026-07-29 |
| Rebecca Byam | CFO | — | 19 | $1.7M | 2026-05-22 |
| Scott T. Garrett | Dir | — | 5 | $1.6M | 2026-07-29 |
| Lee Flowers | VP | — | 7 | $461K | 2026-07-29 |
| Peter Rhode | — | — | 1 | $100K | 2023-12-11 |
| Gary M. Winer | Dir | — | 8 | $89K | 2025-05-16 |
| Rick S. Greene | Dir | — | 3 | $50K | 2025-05-08 |
| Jin-an Jiao | VP of Development | — | 1 | $24K | 2022-05-31 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Lee Flowers | VP | Buy | $20K | 2026-07-29 |
| Hing C. Wong | CEO & 10% Owner | Buy | $60K | 2026-07-29 |
| Rebecca Byam | CFO | Buy | $20K | 2026-05-22 |
| Hing C. Wong | CEO & 10% Owner | Buy | $160K | 2026-05-22 |
| Scott T. Garrett | Director | Buy | $250K | 2026-05-22 |
| Gary M. Winer | Director | Buy | $10K | 2025-05-16 |
Companies that share insiders with HCWB, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Scott T. Garrett | Director | Buy | $200K | 2025-05-16 |
| Hing C. Wong | CEO | Buy | $120K | 2025-05-16 |
| Rick S. Greene | Director | Buy | $25K | 2025-05-08 |
| Gary M. Winer | Director | Buy | $60K | 2025-05-08 |
| Hing C. Wong | CEO | Buy | $2.4M | 2025-05-08 |
| Rebecca Byam | CFO | Buy | $220K | 2025-05-08 |
| Scott T. Garrett | Director | Buy | $140K | 2025-05-08 |
| Hing C. Wong | CEO | Buy | $4K | 2023-09-14 |
| Rebecca Byam | CFO | Buy | $11K | 2023-09-13 |